These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
191 related items for PubMed ID: 9352747
1. Lymphoid blast crisis during complete cytogenetic remission following interferon-alpha and hydroxyurea therapy. Bose S, Chowdhry VP, Saxena R, Kucheria K. Acta Haematol; 1997; 98(3):155-9. PubMed ID: 9352747 [Abstract] [Full Text] [Related]
2. Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib. Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF, Berthou C, Braekeleer MD. Eur J Haematol; 2003 Apr; 70(4):235-9. PubMed ID: 12656747 [Abstract] [Full Text] [Related]
3. Chronic Myeloid Leukemia with cryptic Philadelphia translocation and extramedullary B-lymphoid blast phase as an initial presentation. Soliman DS, Amer AM, Mudawi D, Al-Sabbagh Z, Alkuwari E, Al-Sabbagh A, Ibrahim F, Yassin MA. Acta Biomed; 2018 Apr 03; 89(3-S):38-44. PubMed ID: 29633732 [Abstract] [Full Text] [Related]
6. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression. Lee DS, Lee YS, Yun YS, Kim YR, Jeong SS, Lee YK, She CJ, Yoon SS, Shin HR, Kim Y, Cho HI. Genes Chromosomes Cancer; 2003 Jul 03; 37(3):291-9. PubMed ID: 12759927 [Abstract] [Full Text] [Related]
9. Does BCR-ABL genomic rearrangement persist in CML patients in complete remission after interferon alpha therapy? Brizard F, Chomel JC, Veinstein A, Rivet J, Giraud C, Kitzis A, Guilhot F, Brizard A. Leukemia; 1998 Jul 03; 12(7):1076-80. PubMed ID: 9665193 [Abstract] [Full Text] [Related]
10. Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon. Kawakubo K, Ohyashiki JH, Ohyashiki K, Tauchi T, Ohto T, Toyama K. Cancer Genet Cytogenet; 1992 Feb 03; 58(2):165-8. PubMed ID: 1551082 [Abstract] [Full Text] [Related]
11. A cytogenetic and fluorescence in situ hybridization evaluation of interferon-alpha in the treatment of chronic myeloid leukemia. Itoh T, Tamura S, Takemoto Y, Kakishita E. Int J Mol Med; 1999 Dec 03; 4(6):659-63. PubMed ID: 10567680 [Abstract] [Full Text] [Related]
12. Philadelphia-chromosome-positive T-lymphoblastic leukemia: acute leukemia or chronic myelogenous leukemia blastic crisis. Raanani P, Trakhtenbrot L, Rechavi G, Rosenthal E, Avigdor A, Brok-Simoni F, Leiba M, Amariglio N, Nagler A, Ben-Bassat I. Acta Haematol; 2005 Dec 03; 113(3):181-9. PubMed ID: 15870488 [Abstract] [Full Text] [Related]
13. Molecular monitoring of response to imatinib (Glivec) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission. Paschka P, Müller MC, Merx K, Kreil S, Schoch C, Lahaye T, Weisser A, Petzold A, König H, Berger U, Gschaidmeier H, Hehlmann R, Hochhaus A. Leukemia; 2003 Sep 03; 17(9):1687-94. PubMed ID: 12970765 [Abstract] [Full Text] [Related]
14. Predominantly BCR-ABL negative myeloid precursors in interferon-alpha treated chronic myelogenous leukemia: a follow-up study of peripheral blood colony-forming cells with fluorescence in situ hybridization. Sick C, Schultheis B, Pasternak G, Kottke I, Hörner S, Heissig B, Hehlmann R. Ann Hematol; 2001 Jan 03; 80(1):9-16. PubMed ID: 11233781 [Abstract] [Full Text] [Related]
15. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias]. Becher R, Kloke O. Verh Dtsch Ges Pathol; 1990 Jan 03; 74():36-42. PubMed ID: 1708614 [Abstract] [Full Text] [Related]